Marina Biotech, Inc. - FORM 8-K - EX-23.1 - CONSENT OF WOLF & COMPANY, P.C. - November 5, 2010

Attached files
FileFilename
EX-4.1 - FORM OF SUBSCRIPTION INVESTMENT UNIT - Marina Biotech, Inc.dex41.htm
EX-4.2 - FORM OF WARRANT - Marina Biotech, Inc.dex42.htm
EX-10.1 - AMENDMENT TO THE SECURITIES PURCHASE AGREEMENTS - Marina Biotech, Inc.dex101.htm
EX-10.2 - SECURITIES PURCHASE AGREEMENT - Marina Biotech, Inc.dex102.htm
EX-99.1 - PRESS RELEASE - Marina Biotech, Inc.dex991.htm
8-K - CURRENT REPORT ON FORM 8-K - Marina Biotech, Inc.d8k.htm

 

Exhibit 23.1

CONSENT OF INDEPENDENT AUDITOR

We consent to the incorporation by reference into the Prospectus Supplement dated November 5, 2010 to the Registration Statement (No. 333-168447) on Form S-3/A of Marina Biotech, Inc. of our report dated April 12, 2010, with respect to the financial statements of Cequent Pharmaceuticals, Inc. for the years ended December 31, 2009 and 2008 and for the period from November 10, 2003 (inception) to December 31, 2009.

We also consent to the reference to our firm under the caption “Experts” in such Prospectus Supplement.

 

/s/ Wolf & Company, P.C.
Wolf & Company, P.C.
Boston, Massachusetts
November 3, 2010

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA


This web site and associated pages are not associated with, endorsed by, or sponsored by Marina Biotech, Inc. and has no official or unofficial affiliation with Marina Biotech, Inc.


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.